Stato progetto
212%
finanziata
Condividi
Dati finanziari (05/08/2025)
Ammontare raccolto
GBP
63.758.466,00
Obiettivo minimo
GBP
30.000.000,00
Investimento minimo
GBP
4.726,00
Dettagli
Nazione
Gran Bretagna
Tipologia
Equity
Termine raccolta
05/08/2025
(325 giorni)
investitori
160
Descrizione
“Digostics is transforming diabetes care with GTT@home — the world’s first at-home oral glucose tolerance test (OGTT). Our CE-marked digital platform delivers home-based diabetes screening, supporting earlier detection and relieving healthcare system pressures. Adopted by NHS Trusts and approved in multiple markets, Digostics is redefining diabetes detection.”